Liquid Biopsy
Merck & Co. Partners with Guardant Health on Multi-Year Oncology Collaboration for Biomarker-Driven Cancer Therapies
Merck; Guardant Health; oncology collaboration; liquid biopsy; companion diagnostics; Infinity Smart platform; Keytruda
Spotlight On: Five key oncology stories to watch in 2026
oncology 2026; cancer research trends; FDA oncology decisions 2026; antibody-drug conjugates; radiopharmaceuticals; liquid biopsy; mRNA cancer vaccines; AI in oncology; cell therapies CAR-T TIL TCR; precision oncology
Astrin Biosciences Announces Scientific Advisory Board to Advance Early Cancer Detection Leveraging AI and Proteomics
Astrin Biosciences; Scientific Advisory Board; early cancer detection; AI; proteomics; liquid biopsy; cancer intelligence
Recent Trends in Biomarker Testing for NSCLC: Maximizing Real-World Survival
NSCLC; biomarker testing; overall survival; PD-L1; EGFR; ALK; next-generation sequencing; liquid biopsy; precision medicine; real-world data
Advancements in ctDNA Testing for Early Detection of Breast Cancer Recurrence
ctDNA (circulating tumor DNA), Breast Cancer Recurrence, Early Detection, Liquid Biopsy, Whole Genome Sequencing, Molecular Residual Disease
EU High Court Rules in Favor of Illumina in Grail Acquisition Appeal
Illumina, Grail, European Court of Justice, Acquisition, Antitrust Litigation, Liquid Biopsy
Early Detection and Personalized Treatment of Colorectal Cancer: The Promise of Whole Genome Sequencing-Based Circulating Tumor DNA Tracking” ###
Circulating tumor DNA (ctDNA), Whole genome sequencing (WGS), Colorectal cancer, Early detection, Personalized treatment, Adjuvant therapy, Molecular residual disease (MRD), Liquid biopsies